Premium
Puma Biotechnology Inc (PBYI)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Puma Biotechnology Inc is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357. Puma Biotechnology Inc is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357.
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on January 2, 2025, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement...
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines®...
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on December 2, 2024, the Compensation Committee of Puma’s Board of Directors approved the grant of an...
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the initiation of its ALISertib in CAncer (ALISCA™-Breast1) Phase II trial (PUMA-ALI-1201; NCT06369285) of...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 3.02 | 3.17 | 2.92 | 334972 | 3.01763054 | CS |
| 4 | -0.1 | -3.20512820513 | 3.12 | 4.06 | 2.92 | 734634 | 3.26731946 | CS |
| 12 | -0.47 | -13.4670487106 | 3.49 | 4.06 | 2.32 | 626619 | 3.09772517 | CS |
| 26 | -0.65 | -17.7111716621 | 3.67 | 4.13 | 2.225 | 450847 | 2.98980035 | CS |
| 52 | -1.74 | -36.5546218487 | 4.76 | 7.73 | 2.225 | 487554 | 3.97364889 | CS |
| 156 | 0.75 | 33.0396475771 | 2.27 | 7.73 | 1.6 | 368531 | 3.59360217 | CS |
| 260 | -4.99 | -62.2971285893 | 8.01 | 15 | 1.6 | 518825 | 6.93709503 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
